Maravai LifeSciences Holdings reported earnings of -$ 0.03 per MRVI share on Nov 4, 2026, falling short of analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | -$ 0.06 |
| Earnings Per Share (Surprise) | -$ 0.03 (+$ 0.02631) |
| Last Year's EPS | -$ 0.07 |
| EPS YoY Change |
Out of the last 28 earnings reporting periods, Maravai LifeSciences Holdings beat analysts’ expectations 14 times and fell short of expectations 10 time(s). Maravai LifeSciences Holdings reported earnings per share of -$ 0.03 in the last report surpassing an estimated EPS of -$ 0.06 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.06 | -$ 0.03 | -$ 0.08 | |
| Aug 6, 2026 | -$ 0.04 | -$ 0.02 | -$ 0.08 | |
| May 7, 2026 | -$ 0.05 | $ 0.01 | -$ 0.08 | |
| Feb 25, 2026 | -$ 0.07 | -$ 0.04 | -$ 0.06 | |
| Nov 6, 2025 | -$ 0.06 | -$ 0.08 | -$ 0.02 | |
| Aug 11, 2025 | -$ 0.06 | -$ 0.08 | -$ 0.08 | |
| May 12, 2025 | -$ 0.07 | -$ 0.08 | -$ 0.02 | |
| Mar 18, 2025 | -$ 0.03 | -$ 0.06 | $ 0.01 | |
| Nov 7, 2024 | -$ 0.01 | -$ 0.02 | -$ 0.01 | |
| Aug 7, 2024 | -$ 0.04 | -$ 0.08 | -$ 0.06 | |
| May 8, 2024 | -$ 0.02 | -$ 0.02 | $ 0.03 | |
| Feb 22, 2024 | $ 0.00351 | $ 0.01 | $ 0.35 | |
| Nov 7, 2023 | $ 0.00 | -$ 0.01 | $ 0.37 | |
| Aug 7, 2023 | -$ 0.03 | -$ 0.06 | $ 0.54 | |
| May 8, 2023 | $ 0.03625 | $ 0.03 | $ 0.54 | |
| Feb 22, 2023 | $ 0.34 | $ 0.35 | $ 0.45 | |
| Nov 2, 2022 | $ 0.32 | $ 0.37 | $ 0.44 | |
| Aug 4, 2022 | $ 0.45 | $ 0.54 | $ 0.44 | |
| May 5, 2022 | $ 0.44 | $ 0.54 | $ 0.26 | |
| Feb 23, 2022 | $ 0.38 | $ 0.45 | $ 0.13 |
Maravai LifeSciences Holdings’s stock was trading at $ 7.45 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, MRVI’s price decreased to $ 6.98 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.03 | $ 7.45 | $ 6.98 | |
| Aug 6, 2026 | -$ 0.02 | $ 6.41 | $ 6.23 | |
| May 7, 2026 | $ 0.01 | $ 3.94 | $ 4.85 | |
| Feb 25, 2026 | -$ 0.04 | $ 3.12 | $ 3.56 | |
| Nov 6, 2025 | -$ 0.08 | $ 2.87 | $ 2.87 | |
| Aug 11, 2025 | -$ 0.08 | $ 2.20 | $ 2.69 | |
| May 12, 2025 | -$ 0.08 | $ 1.98 | $ 2.06 | |
| Mar 18, 2025 | -$ 0.06 | $ 2.64 | $ 2.43 | |
| Nov 7, 2024 | -$ 0.02 | $ 8.03 | $ 5.08 | |
| Aug 7, 2024 | -$ 0.08 | $ 9.09 | $ 8.48 | |
| May 8, 2024 | -$ 0.02 | $ 8.96 | $ 9.86 | |
| Feb 22, 2024 | $ 0.01 | $ 5.26 | $ 8.36 | |
| Nov 7, 2023 | -$ 0.01 | $ 6.84 | $ 4.70 | |
| Aug 7, 2023 | -$ 0.06 | $ 11.50 | $ 11.10 | |
| May 8, 2023 | $ 0.03 | $ 14.47 | $ 12.09 | |
| Feb 22, 2023 | $ 0.35 | $ 14.00 | $ 14.96 | |
| Nov 2, 2022 | $ 0.37 | $ 16.43 | $ 14.51 | |
| Aug 4, 2022 | $ 0.54 | $ 26.31 | $ 26.88 | |
| May 5, 2022 | $ 0.54 | $ 30.51 | $ 32.37 | |
| Feb 23, 2022 | $ 0.45 | $ 34.03 | $ 33.50 |
Maravai LifeSciences Holdings released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Maravai LifeSciences Holdings beat analysts’ expectations during the last earnings period by
